0 Σχόλια
0 Μοιράστηκε
3χλμ. Views
0 Προεπισκόπηση
Αναζήτηση
Ανακάλυψε νέους ανθρώπους, δημιούργησε νέες συνδέσεις και κάνε καινούργιους φίλους
-
Παρακαλούμε συνδέσου στην Κοινότητά μας για να δηλώσεις τι σου αρέσει, να σχολιάσεις και να μοιραστείς με τους φίλους σου!
-
Generic Drug Market Size, Share, Trends, Key Drivers, Demand and Opportunity Analysis"Executive Summary Generic Drug Market Size and Share: Global Industry Snapshot Data Bridge Market Research analyses that the generic drug market, which is USD 622.02 million in 2022, is expected to reach USD 1,323.68 million by 2030, at a CAGR of 9.9% during the forecast period 2023 to 2030. In addition to the insights on market scenarios such as market value, growth rate,...0 Σχόλια 0 Μοιράστηκε 45 Views 0 Προεπισκόπηση
-
MENA Generic Oncology Drug Market, Size, Share, Growth and forecast (2024-2032)According to the UnivDatos, the growing awareness of generic medicines in the region will drive the scenario of Generic Oncology Drugs and as per their “MENA Generic Oncology Drug Market” report, the Saudi Arabia Market was valued at USD ~4 billion in 2022, growing at a CAGR of 3% during the forecast period from 2024 - 2032 to reach USD billion by 2030. The Saudi Arabia region is...0 Σχόλια 0 Μοιράστηκε 1χλμ. Views 0 Προεπισκόπηση
-
Global Raloxifene Hydrochloride Market Growing at 5.8% CAGR Driven by Dual Benefits in Bone Health & Cancer PreventionAccording to a new report from Intel Market Research, the global Raloxifene Hydrochloride market was valued at USD 1.05 billion in 2025 and is projected to reach USD 1.75 billion by 2034, growing at a steady CAGR of 5.8% during the forecast period (2026-2034). This growth is fueled by increasing osteoporosis prevalence among aging populations, expanding applications in breast cancer prevention,...0 Σχόλια 0 Μοιράστηκε 816 Views 0 Προεπισκόπηση
-
Global Trospium Chloride Market to Reach USD 49.7 Million by 2034 Amid Rising OAB CaseAccording to a new report from Intel Market Research, the global Trospium Chloride market was valued at USD 36.9 million in 2024 and is projected to reach USD 49.7 million by 2034, growing at a steady CAGR of 4.4% during the forecast period (2025-2034). This growth is driven by increasing overactive bladder (OAB) prevalence, aging populations requiring urological care, and pharmaceutical...0 Σχόλια 0 Μοιράστηκε 214 Views 0 Προεπισκόπηση